Ocular Oncology News

The addition of intravitreal chemotherapy to strategies for treating retinoblastoma represents an improvement in management of the disease, according to a study.

Despite improving treatment, the rate of metastasis of uveal melanoma is not decreasing, possibly due to early micrometastasis of the tumors when they are relatively small, according to J. William Harbour, MD, of Bascom Palmer Eye Institute. At Retina 2016, Harbour presented his thoughts on systemic management of uveal melanoma.

At Kiawah Eye, George Magrath, MD, of Wills Eye Hospital, Philadelphia, describes how to differentiate types of lacrimal gland lesions using magnetic resonance imaging to measure water motion in tissue.

Fine-needle aspiration biopsy of orbital lesions was determined to be an effective technique for cytologic diagnoses and may help avoid open biopsy, according to a study.

The FDA granted orphan drug designation to IMCgp100 for the treatment of uveal melanoma.

BARCELONA — Salutaris Medical Devices has received 510(k) clearance from FDA for its SMD Sr90-1 radionuclide brachytherapy source, according to a press release.

A 32-year-old woman was referred to the New England Eye Center by an optometrist for conjunctival cysts and concern for a possible neoplasm in the left eye.

A 32-year-old woman was referred to the New England Eye Center by an optometrist for conjunctival cysts and concern for a possible neoplasm in the left eye.

A 12-year-old boy presented to our hospital complaining of his left eye “moving gradually downward.”

PHILADELPHIA — Uveal metastatic cancer from lung cancer had a high globe salvage rate but a poor systemic prognosis, according to a study presented at the Wills Eye Alumni Conference.